Jane Street Group, LLC Kymera Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 16, 2022	SELL	$14.13 - $42.55 $166,734 - $502,089	-11,800 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$35.3 - $64.68 $3.82 Million - $7 Million	-108,200 Reduced 90.17%	11,800 $499,000
Q4 2021 Feb 15, 2022	BUY	$49.91 - $65.56 $3.24 Million - $4.26 Million	65,000 Added 118.18%	120,000 $7.62 Million
Q3 2021 Nov 16, 2021	BUY	$47.8 - $66.66 $2.63 Million - $3.67 Million	55,000 New	55,000 $3.23 Million

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.22B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.